Drug-eluting bead transarterial chemoembolization (TACE) exhibits superior efficacy and equal tolerance to conventional TACE in hepatocellular carcinoma patients with conventional TACE history-Reference-Cited by-同舟云学术

Drug-eluting bead transarterial chemoembolization (TACE) exhibits superior efficacy and equal tolerance to conventional TACE in hepatocellular carcinoma patients with conventional TACE history

Published:2022-03 Issue:3 Volume:46 Page:101814
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Tang Junjun,Huang Zongliang,Xu Jichong,Lv Qi,Wang Peijun

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Hepatocellular carcinoma;Forner;Lancet,2018

2. Epidemiology and management of hepatocellular carcinoma;Kulik;Gastroenterology,2019

3. The evolving epidemiology of hepatocellular carcinoma: a global perspective;Wallace;Expert Rev Gastroenterol Hepatol,2015

4. Hepatocellular carcinoma: review of epidemiology, screening, imaging diagnosis, response assessment, and treatment;Clark;Curr Probl Diagn Radiol,2015

5. The diagnosis and treatment of hepatocellular carcinoma;Hartke;Semin Diagn Pathol,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of CalliSpheres® microspheres versus conventional transarterial chemoembolization in the treatment of refractory colorectal cancer liver metastasis;BMC Cancer;2023-10-12

2. Comparison of the Treatment Response of Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma;Cureus;2023-07-11

3. Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer;Canadian Journal of Gastroenterology and Hepatology;2023-04-26

4. Efficacy and Safety of TACE Combined with Regorafenib versus TACE in the Third-Line Treatment of Colorectal Liver Metastases;Journal of Oncology;2022-12-03